KO · Healthcare

Dongwha Pharm.Co.Ltd (000020)

Drug Manufacturers - Specialty & Generic

Dongwha Pharm.Co.Ltd (000020) is listed on KO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 000020

P/E ratio

18.00

Dongwha Pharm.Co.Ltd (000020) — FAQ

What is 000020's P/E ratio?

The price-to-earnings (P/E) ratio for Dongwha Pharm.Co.Ltd (000020) is 18.00 (data as of 2026-05-24).

Does Dongwha Pharm.Co.Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Dongwha Pharm.Co.Ltd (000020). Check the MyAverix Finance app for the latest dividend data.

What sector is Dongwha Pharm.Co.Ltd in?

Dongwha Pharm.Co.Ltd (000020) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 000020 listed on?

000020 is listed on KO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)